
Number of publications published per year by Sass, Gabriele. (Source : PubMed)

Distribution of publications types for Sass, Gabriele. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.
Cellular oncology : the official journal of the International Society for Cellular Oncology
2010
The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.
Hepatology
2010;51;2
A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Gut
2009;58;12
The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice.
Int. J. Oncol.
2008;33;4
Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice.
Int. J. Cancer
2008;123;6
Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting.
Virology
2008;370;1
TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax.
J. Immunol.
2007;179;10
Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
Gastroenterology
2007;133;4
[ See timeline ] [ See all publications ]
means that Sass, Gabriele has 17 papers cited a least 17 times - methodology
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, 91054 Erlangen, Germany.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.